These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15777262)

  • 21. Transglutaminases in skin epidermis.
    Hitomi K
    Eur J Dermatol; 2005; 15(5):313-9. PubMed ID: 16172037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of transglutaminases in human breast cancer and their possible clinical significance.
    Jiang WG; Ablin R; Douglas-Jones A; Mansel RE
    Oncol Rep; 2003; 10(6):2039-44. PubMed ID: 14534740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-1 induces pro-mineralizing activity of cartilage tissue transglutaminase and factor XIIIa.
    Johnson K; Hashimoto S; Lotz M; Pritzker K; Terkeltaub R
    Am J Pathol; 2001 Jul; 159(1):149-63. PubMed ID: 11438463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transglutaminase inhibition as a possible therapeutical approach to protect cells from death in neurodegenerative diseases.
    Iannaccone M; Serretiello E; De Vivo G; Martin A; Stefanile A; Titta F; Gentile V
    Recent Pat CNS Drug Discov; 2013 Aug; 8(2):161-8. PubMed ID: 23688272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitors of tissue transglutaminase.
    Keillor JW; Apperley KY; Akbar A
    Trends Pharmacol Sci; 2015 Jan; 36(1):32-40. PubMed ID: 25500711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transglutaminases, thioredoxins and protein disulphide isomerase: diverse enzymes with a common goal of cross-linking proteins in lower organisms.
    Rao RU; Mehta K
    Indian J Exp Biol; 2004 Mar; 42(3):235-43. PubMed ID: 15233291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetic analysis of the interaction of tissue transglutaminase with a nonpeptidic slow-binding inhibitor.
    Case A; Stein RL
    Biochemistry; 2007 Jan; 46(4):1106-15. PubMed ID: 17240993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cinnamoyl inhibitors of tissue transglutaminase.
    Pardin C; Pelletier JN; Lubell WD; Keillor JW
    J Org Chem; 2008 Aug; 73(15):5766-75. PubMed ID: 18582115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chondrocyte-derived transglutaminase promotes maturation of preosteoblasts in periosteal bone.
    Nurminskaya M; Magee C; Faverman L; Linsenmayer TF
    Dev Biol; 2003 Nov; 263(1):139-52. PubMed ID: 14568552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue transglutaminase: a novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases.
    Wilhelmus MM; van Dam AM; Drukarch B
    Eur J Pharmacol; 2008 May; 585(2-3):464-72. PubMed ID: 18417122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A fluorescence anisotropy-based assay for determining the activity of tissue transglutaminase.
    Hauser C; Wodtke R; Löser R; Pietsch M
    Amino Acids; 2017 Mar; 49(3):567-583. PubMed ID: 26886924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of two transglutaminases derived from same zymogen for the Streptomyces hygroscopicus and analysis of their formation processes.
    Cui W; Yang X; Fang Y; Zhou S; Liu S; Du G; Du K; Chen J; Tao G; Zhou Z
    J Sci Food Agric; 2013 May; 93(7):1711-7. PubMed ID: 23355183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transglutaminase activity in aging articular chondrocytes and articular cartilage vesicles.
    Rosenthal AK; Derfus BA; Henry LA
    Arthritis Rheum; 1997 May; 40(5):966-70. PubMed ID: 9153560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transglutaminase activity as a possible therapeutical target in neurodegenerative diseases.
    Iannaccone M; Titta F; Serretiello E; De Vivo G; Martin A; Gentile V
    Recent Pat CNS Drug Discov; 2013 Dec; 8(3):235-42. PubMed ID: 24286449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased levels of gamma-glutamylamines in Huntington disease CSF.
    Jeitner TM; Matson WR; Folk JE; Blass JP; Cooper AJ
    J Neurochem; 2008 Jul; 106(1):37-44. PubMed ID: 18422943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transglutaminases in mineralized tissues.
    Nurminskaya M; Kaartinen MT
    Front Biosci; 2006 May; 11():1591-606. PubMed ID: 16368540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzyme responsible for egg envelope (chorion) hardening in fish: purification and partial characterization of two transglutaminases associated with their substrate, unfertilized egg chorion, of the rainbow trout, Oncorhynchus mykiss.
    Ha CR; Iuchi I
    J Biochem; 1998 Nov; 124(5):917-26. PubMed ID: 9792914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transglutaminase contributes to CPPD crystal formation in osteoarthritis.
    Heinkel D; Gohr CM; Uzuki M; Rosenthal AK
    Front Biosci; 2004 Sep; 9():3257-61. PubMed ID: 15353354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in the development of tissue transglutaminase (TG2) inhibitors.
    Badarau E; Collighan RJ; Griffin M
    Amino Acids; 2013 Jan; 44(1):119-27. PubMed ID: 22160259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dependence of Giardia lamblia encystation on novel transglutaminase activity.
    Davids BJ; Mehta K; Fesus L; McCaffery JM; Gillin FD
    Mol Biochem Parasitol; 2004 Aug; 136(2):173-80. PubMed ID: 15478797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.